Pacifichealth Laboratories Stock Z Score
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
PacificHealth |
PacificHealth Laboratories Company Z Score Analysis
PacificHealth Laboratories' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current PacificHealth Laboratories Z Score | -11.0 |
Most of PacificHealth Laboratories' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, PacificHealth Laboratories has a Z Score of -11.0. This is 221.41% lower than that of the Personal Products sector and notably lower than that of the Consumer Staples industry. The z score for all United States stocks is notably higher than that of the company.
PacificHealth Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PacificHealth Laboratories' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PacificHealth Laboratories could also be used in its relative valuation, which is a method of valuing PacificHealth Laboratories by comparing valuation metrics of similar companies.PacificHealth Laboratories is currently under evaluation in z score category among its peers.
PacificHealth Fundamentals
Return On Equity | -0.75 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.14) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 571.89 K | ||||
Shares Outstanding | 20.87 M | ||||
Price To Earning | (0.34) X | ||||
Price To Book | 0.71 X | ||||
Price To Sales | 0.07 X | ||||
Revenue | 6.91 M | ||||
Gross Profit | 2.99 M | ||||
EBITDA | (861.23 K) | ||||
Net Income | (486.31 K) | ||||
Cash And Equivalents | 324.48 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 54.86 K | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (503.96 K) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 2.8 | ||||
Beta | -275.06 | ||||
Market Capitalization | 87 | ||||
Total Asset | 1.89 M | ||||
Retained Earnings | (20.59 M) | ||||
Working Capital | 676 K | ||||
Current Asset | 1.84 M | ||||
Current Liabilities | 1.17 M | ||||
Z Score | -11.0 | ||||
Net Asset | 1.89 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |